Please find enclosed herewith the Newspaper Intimation under Regulation 47 of SEBI (LODR) Regulations, 2015 for your reference.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Boston Bio Systems Limited (BSE Scrip Code: 531458) has submitted a newspaper publication intimation to BSE under Regulation 47 of the SEBI LODR Regulations, 2015. The company enclosed copies of newspaper advertisements published in Financial Express (English) on 1st June 2025 and Financial Express (Gujarati) on 2nd June 2025, carrying the audited standalone financial results for the quarter and full year ended 31st March 2025. These results were approved at the Board of Directors' meeting held on 30th May 2025. The intimation is signed by Director Ghanshyam Dhananjay Gavali (DIN: 03343352). The company's registered office is in Ahmedabad, Gujarat.
This is a routine regulatory compliance filing confirming that the already-approved Q4/FY25 results have been published in newspapers as required. No new material information is being disclosed here, so it should have no meaningful impact on the stock price.